John Abraham: Understanding rFVIIa Through the Cell Based Model of Coagulation
John Abraham, Assistant Professor at Christian Medical College and Hospital, shared a post on LinkedIn:
“Recently co-authored a chapter on clotting disorders in pregnancy.
While writing it, I went back and deep dived into the cell-based model of coagulation — and somewhere along the way, something just clicked.
Revisiting the model :
- Initiation gives only a small thrombin signal
- Amplification prepares the platelet surface
- Propagation is where the real action happens – thrombin burst
The system is designed so that effective clotting is platelet-surface driven
The moment of clarity: rFVIIa (NovoSeven)
While going through this, the mechanism suddenly made complete sense:
- If clot formation depends on platelet-surface thrombin generation
- Then you don’t necessarily need the entire intrinsic pathway
rFVIIa at pharmacologic doses:
- Acts directly on activated platelets
- Generates FXa independent of TF
- Bypasses FVIII / FIX
Result: restoration of the thrombin burst exactly where it matters
Why this felt important:
- Explains its efficacy in hemophilia with inhibitors
- Connects physiology – pharmacology in a very direct way
- Turns what feels like a ‘black box drug’ into a predictable mechanism
A good reminder — sometimes revisiting what you already know, but in depth, can change how clearly you see it.”
Stay updated with Hemostasis Today.
-
Mar 18, 2026, 15:18Ossama Mansour: First Resource Stratified Guidelines for Acute Ischemic Stroke in the MENA Region
-
Mar 18, 2026, 15:16Ifeanyichukwu Ifechidere: Interpreting Abnormal Coagulation Results Through Two Practical Cases
-
Mar 18, 2026, 15:14Heghine Khachatryan: Platelets and Cancer Metastasis – More Than Just Hemostasis
-
Mar 18, 2026, 15:13Bhavna Gupta: When Not to Use AI in Clinical Practice
-
Mar 18, 2026, 12:53Maxime Dely: Why I Took My Toddler to a Blood Donation Session
-
Mar 18, 2026, 12:22Anita Brikman: Advancing Plasma-Derived Therapies in India Through Global Collaboration
-
Mar 18, 2026, 12:17Ben Samelson-Jones: Long-Term Safety and Efficacy of AAV Gene Therapy Using FIX-Padua in Hemophilia B
-
Mar 18, 2026, 12:14Sakditad Saowapa: Optimizing Sexual Activity and Minimizing Infection Risk in Patients with Neutropenia
-
Mar 17, 2026, 18:11Ossama Mansour: Landmark MENA Guidelines for Acute Ischemic Stroke Management